Abstract: The invention relates to a refrigerant for use in a single-stage or auto cascade refrigeration system. The refrigerant comprises a mixture of gasses of at least three different hydrocarbons. The at least three different hydrocarbons include butane (C4H10), ethene (C2H4) and methane (CH4). The mixture of gasses comprises at the most 10% by weight of methane (CH4). The invention also relates to a refrigeration system with methane-containing refrigerant, to a refrigeration cabinet with methane-containing refrigerant and to use of a refrigeration cabinet with such refrigerant.

Abstract: Disclosed is a method for estimating the range to an object, the method comprising: transmitting a first signal towards the object; receiving a reflected echo signal reflected from the object; and determining a measured point (MP) in an N-dimensional phase space. The range to the object is estimated by selecting a candidate range estimate from a plurality of candidate range estimates, each candidate range estimate in the unambiguous range R having an unique associated point in the N-dimensional phase space positioned on range lines, and wherein a candidate range estimate is selected dependent on the distance from its unique associated point in the N-dimensional phase space to the measured point (MP), so that a single range estimate is generated using information from at least two measured phase differences without directly averaging ambiguous range estimates.

Abstract: Disclosed is a method for generating a quality measure for a frequency set. The quality measure indicates the quality of the frequency set for use in a multi frequency ranging method for estimating the range to an object. The method for generating a quality measure comprises the steps of determining the smallest distance between any two range lines of a set of range lines in an N-dimensional phase space. The N-dimensional phase space comprises at least a first dimension representing a first phase difference, and a second dimension representing a second phase difference. The N-dimensional phase space has a dimension equal to the number of phase differences used by the multi frequency ranging method. The range lines represent all theoretical possible combinations of the phase differences.

Abstract: Linear actuator, where a reversible electric motor (20) through a transmission (21) drives a non-self-locking spindle (22), by means of which an adjustment element (24) secured against rotation can be moved axially for adjusting an element connected thereto such as a backrest section in a bed. The actuator further comprises a quick release (27) for disengagement of the adjustment element (24) from the electric motor (20) and the part of the transmission (21) extending from the electric motor (20) to the quick release (27), such that the spindle (22) is rotated under the load on the adjustment element (24). Further, the actuator comprises brake means for controlling the speed of the adjustment element (24), when the quick release (27) is activated.

Abstract: Linear actuator, where a reversible electric motor (20) through a transmission (21) drives a non-self-locking spindle (22), by means of which an adjustment element (24) secured against rotation can be moved axially for adjusting an element connected thereto such as a backrest section in a bed. The actuator further comprises a quick release (27) for disengagement of the adjustment element (24) from the electric motor (20) and the part of the transmission (21) extending from the electric motor (20) to the quick release (27), such that the spindle (22) is rotated under the load on the adjustment element (24). Further, the actuator comprises brake means for controlling the speed of the adjustment element (24), when the quick release (27) is activated.

Abstract: Disclosed is a method for estimating the range to an object, the method comprising: transmitting a first signal towards the object; receiving a reflected echo signal reflected from the object; and determining a measured point (MP) in an N-dimensional phase space. The range to the object is estimated by selecting a candidate range estimate from a plurality of candidate range estimates, each candidate range estimate in the unambiguous range R having an unique associated point in the N-dimensional phase space positioned on range lines, and wherein a candidate range estimate is selected dependent on the distance from its unique associated point in the N-dimensional phase space to the measured point (MP), so that a single range estimate is generated using information from at least two measured phase differences without directly averaging ambiguous range estimates.

Abstract: Disclosed is a method for generating a quality measure for a frequency set. The quality measure indicates the quality of the frequency set for use in a multi frequency ranging method for estimating the range to an object. The method for generating a quality measure comprises the steps of determining the smallest distance between any two range lines of a set of range lines in an N-dimensional phase space. The N-dimensional phase space comprises at least a first dimension representing a first phase difference, and a second dimension representing a second phase difference. The N-dimensional phase space has a dimension equal to the number of phase differences used by the multi frequency ranging method. The range lines represent all theoretical possible combinations of the phase differences.

Abstract: Provided are methods of diagnosing high risk adenomas or colorectal cancer by detecting the presence and/or amount of at least three biomarkers of CRC in a sample from a subject. The methods and biomarkers may be used to develop an accurate prognosis for a patient having CRC or at risk of having CRC or accurately diagnose a subject having or at risk of having CRC. The methods and biomarkers may be used to identify and/or classify a patient as a candidate for further CRC screening and/or CRC treatment therapy.

Abstract: Modular system (2) comprising at least two modules (1), said modules comprising a shelf top panel (3) and an oppositely placed shelf bottom panel (4), said two panels being mutually connected by a first shelf side panel (5) and an oppositely placed second shelf side panel (6) for providing a box-shaped module (1). Said module (1) comprises positioning means 89) adapted to position one module (1) to a second module (1), and the modular system (2) also comprises at least one extension panel (8), said extension panel (8) comprising fastening means adapted to engage with the positioning means, whereby the extension panel is secured.

Abstract: The present invention relates to methods of diagnosing the presence of a non-specific disease or disorder in a subject, wherein a determined level of YKL-40 above a reference level indicates the presence of a non-specific disease or disorder. The subject may suffer from a variety of diseases or disorders. The reference level may be a reference level obtained from healthy individuals or it may be a previous measurement obtained from the same subject. The present invention furthermore relates to a method for classifying the severity of a non-specific disease or disorder in a subject, wherein a determined level of YKL-40 above or below one or more reference levels gives the severity of said non-specific disease or disorder. The present invention further relates to a kit and a device that may be used in the method of the present invention comprising means for measuring the level of YKL-40 in a sample; and means for comparing the measured level of YKL-40 with at least one reference level of YKL-40.

Abstract: The present invention relates to gastrointestinal cancers and methods for selecting a treatment for said gastrointestinal cancer in a subject. The present invention further relates to a methods of diagnosing the presence of and/or classifying the severity of a gastrointestinal cancer; together with methods for determining the effect of a therapy administered and/or the prognosis for a subject suffering from a gastrointestinal cancer, before, during or after administering the treatment. For all the methods applies that a determined level of YKL-40 above one or more reference levels indicates the treatment, the severity of the disease, the effect of the treatment and/or the prognosis of the subject. The reference level is typically a level obtained from healthy individuals or a level previously obtained from the same subject. The subject may suffer from any one or more gastrointestinal cancers, such as upper gastrointestinal cancers, and metastatic colorectal cancer.

Abstract: A linear actuator device for pieces of furniture, e.g. beds, is described which include an adjustable section (2, 3) pivotally embedded in a frame (1). The section (2, 3) is raised and lowered by at least one rod (23, 24) mounted on a pivot shaft (4, 6). The actuator comprises a housing (8) with a bushing (10) receiving the pivot shaft (4, 6), and a spindle (14) driven by a low-voltage DC motor (11). The spindle (14) carries a spindle nut (12) fixed against rotation which in one direction of motion operates an arm (5, 7) mounted on the pivot shaft (4, 6) for adjusting the section within the piece of furniture. By designing the arm (5, 7) such that, when it engages the spindle nut (12), it will rest against an area (17) of the nut's end which faces farthest away from the shaft, an expedient moment curve for pivoting the section is obtained, as a large moment occurs at the beginning and the end of the section's movement just when needed.

Abstract: An item of furniture includes a frame mounting two adjustable sections which each includes a pivot shaft to cause pivoting of the respective section relative to the frame. Each pivot shaft mounts a claw-shaped arm having two legs. A dual linear actuator having openings at its opposite ends is suspended from the two claw-shaped arms and is operable to rotate the pivot shafts by engagement of sliding spindle nuts therein with the respective claw-shaped arms.

Abstract: The present invention relates to gastrointestinal cancers and methods for selecting a treatment for said gastrointestinal cancer in a subject. The present invention further relates to a methods of diagnosing the presence of and/or classifying the severity of a gastrointestinal cancer; together with methods for determining the effect of a therapy administered and/or the prognosis for a subject suffering from a gastrointestinal cancer, before, during or after administering the treatment. For all the methods applies that a determined level of YKL-40 above one or more reference levels indicates the treatment, the severity of the disease, the effect of the treatment and/or the prognosis of the subject. The reference level is typically a level obtained from healthy individuals or a level previously obtained from the same subject. The subject may suffer from any one or more gastrointestinal cancers, such as upper gastrointestinal cancers, and metastatic colorectal cancer.

Abstract: The present invention relates to methods of classifying the severity of a non-specific disease or disorder in a subject, wherein a determined level of YKL-40 is compared to one or more reference levels of YKL-40, and the severity of said non-specific disease or disorder is deduced from said comparison. The present invention furthermore relates to a method of classifying the severity of a disease or disorder in a subject, wherein a determined level of YKL-40 is compared to one or more previously determined levels of YKL-40 from the same subject. In both methods, the subject may suffer from a variety of diseases or disorders. In addition the present invention relates to a kit and a device that may be used in the methods of the present invention comprising means for measuring the level of YKL-40 in a sample; and means for comparing the measured level of YKL-40 with one or more reference levels of YKL-40.

Abstract: The present invention relates to a methods for selecting a treatment for a specific disease or disorder, together with a method of monitoring therapeutic treatment of a specific disease or disorder and a method of determining a prognosis for a subject before, during and after administering a treatment by determining the level of YKL-40 in a sample obtained from the subject and comparing said level with one or more reference levels of YKL-40. The reference level is typically a level obtained from healthy individuals or a level previously obtained from the same subject. The present invention further relates to a kit and a device that may be used in the methods of the present invention.

Abstract: A linear actuator, in particular telescopic legs for height-adjustable tables, and comprising an outer profile (18), a spindle (7) mounted at an upper end of the outer profile, a transmission (8) connecting the spindle (7) with a reversible electric motor, a spindle nut (11) secured against rotation on the spindle (7), an intermediate profile (10) mounted with its one end on the spindle nut (11), a guide at a lower end of the outer profile (18) for the intermediate profile (10), a cord element (12, 20; 26) secured at the lower end of the outer profile (18) and connected via a guide with an inner profile (14), such that this together with the intermediate profile (10) is telescopically pushed out of and into the outer profile (18) by the rotation of the spindle.

Abstract: The present invention describes a method for determining whether an individual is suffering from cancer by determining a parameter representing the TIMP-1 concentration in body fluid samples from the individual. The present invention furthermore describes a method for determining whether an individual is suffering from minimal residual disease or recurrent cancer after being treated for the primary cancer by determining a parameter representing the post-operative TIMP-1 concentration in body fluid samples from the individual. In addition, the invention describes the additive effect of combined post-operative measurements of plasma TIMP-1 and serum CEA.

Abstract: A telescopic column, in particular for height-adjustable tables, comprises a first member (1) and a second member (2) arranged telescopically relative to each other, wherein the first member (1) is provided with a rack (12) and the second member (2) with a gear wheel (5) in mesh with the rack. Configuring the rack as a plurality of holes (12) in the member (1) allows the column to be made of a thin sheet.

Abstract: The present invention relates to method for determining whether a gastrointestinal cancer patient is likely to experience a disease recurrence, said method comprising steps of determining concentration of TIMP-1 in a pre-operative plasma sample of said patient, and determining the concentration of CEA in a pre-operative body fluid sample of said patient, and evaluate whether the patient as likely to experience a disease recurrence. The present invention further provides kits for application of said methods.